Minerva Neurosciences Inc...

NASDAQ: NERV · Real-Time Price · USD
2.26
0.46 (25.91%)
At close: Aug 15, 2025, 3:59 PM
2.32
2.85%
After-hours: Aug 15, 2025, 07:47 PM EDT

Minerva Neurosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
22.47K 30.98K 8.51K 101.79K
Gross Profit
n/a -30.98K -8.51K -102K
Operating Income
-21.85M -23.12M -25.23M -45.37M
Interest Income
1.27M 1.44M 556.95K 16.52K
Pretax Income
1.44M -30M -32.11M -51.71M
Net Income
1.44M -30M -32.11M -49.91M
Selling & General & Admin
9.95M 10.38M 10.58M 13.33M
Research & Development
11.9M 12.71M 14.65M 32.04M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
21.83M 23.09M 25.23M 45.37M
Interest Expense
4.56M 8.28M 7.41M 6.33M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
21.85M 23.12M 25.23M 45.37M
Income Tax Expense
n/a n/a 6.88M -1.8M
Shares Outstanding (Basic)
7.57M 6.51M 5.34M 5.34M
Shares Outstanding (Diluted)
7.57M 6.51M 5.34M 5.34M
EPS (Basic)
0.19 -4.61 -6.01 -9.35
EPS (Diluted)
0.19 -4.61 -6.01 -9.35
EBITDA
6.02M -21.69M -24.69M -51.61M
EBIT
6M -21.72M -24.7M -51.71M
Depreciation & Amortization
22.47K 30.98K 8.51K 101.79K